Palleiko Benjamin L
SEC insider (Form 3/4/5 filer). CIK 0001366244. Director at Frazier Life Sciences Acquisition Corp. II (FLSC) and 1 other issuer. 53 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in PALO ALTO, CA.
Companies Palleiko Benjamin L has filed insider reports for
- Frazier Life Sciences Acquisition Corp. II (FLSC): Director
- KalVista Pharmaceuticals, Inc. (KALV): Director, Officer, CHIEF EXECUTIVE OFFICER
Palleiko Benjamin L
CIK: 0001366244
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (53 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirect480K shares- - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect10.9K shares at avg. $26.78$293K - May 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect23.3K shares- - May 18, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.1K shares at avg. $26.76$30K - May 17, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect2.4K shares- - May 12, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect3.3K shares at avg. $26.71$89K - May 11, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect7.1K shares- - Apr 17, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect9.6K shares at avg. $20.22$193K - Apr 16, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect20.3K shares- - Mar 9, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect6.7K shares at avg. $16.08$108K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  KALV KalVista Pharmaceuticals, Inc. | Disposition | 479,989 | - | $0 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 10,926 | $26.78 | $292,646 | Direct |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 23,250 | - | $0 | Direct |
| May 18, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,129 | $26.76 | $30,212 | Direct |
| May 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 2,419 | - | $0 | Direct |
| May 12, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 3,322 | $26.71 | $88,731 | Direct |
| May 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 7,120 | - | $0 | Direct |
| Apr 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 9,550 | $20.22 | $193,066 | Direct |
| Apr 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 20,312 | - | $0 | Direct |
| Mar 9, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 6,693 | $16.08 | $107,633 | Direct |
1-10 of 53 transactions